K. Watanabe

Phase I/II and pharmacologic study of long-term continuous infusion etoposide combined with cisplatin in patients with advanced non-small-cell lung cancer.

H. Kunitoh, K. Watanabe, K. Watanabe, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective study of mutant frequencies at the hprt and T-cell receptor gene loci in pediatric cancer patients during chemotherapy.

K. Furusho, M. Kubota, Y. Akiyama, 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Evaluation of mutant frequencies at the hprt and the T-cell receptor loci in pediatric cancer patients before treatment.

K. Furusho, M. Kubota, Y. Akiyama, 1998, Mutation research.

A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811)

N. Saijo, Y. Nishiwaki, M. Nishio, 2009, British Journal of Cancer.

A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy.

A. Howell, H. Earl, D. Miles, 1998, Blood.

A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer.

K. Eguchi, N. Saijo, Y. Ohe, 1994, European journal of cancer.

Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702

N. Saijo, S. Kudoh, H. Kunikane, 2007, British Journal of Cancer.

Phase II study of area under the plasma-concentration-versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer.

K. Mori, N. Saijo, Y. Nishiwaki, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.

S. Ohnishi, T. Gunji, M. Akahane, 2002, International journal of oncology.